CLOVIS ONCOLOGY, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of November 17, 2020 4.50% Convertible Senior Notes due 2024Indenture • November 17th, 2020 • Clovis Oncology, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of November 17, 2020, between CLOVIS ONCOLOGY, INC., a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
